La banca dati dell’inventario C&L

Summary of Classification and Labelling

Harmonised classification - Annex VI of Regulation (EC) No 1272/2008 (CLP Regulation)

General Information

Index Number	EC / List no.	CAS Number	International Chemical Identification
007-004-00-1	231-714-2	7697-37-2	nitric acid ...% [C > 70 %]

ATP Inserted / Updated: CLP00/ATP15

This field indicates when an entry in Annex VI to CLP has been inserted and/or updated with an Adaptation to Technical Progress (ATP) to the CLP Regulation.

CLP Classification (Table 3)

Classification		Labelling			Specific Concentration limits, M-Factors, Acute Toxicity Estimates (ATE)	Notes
Hazard Class and Category Code(s)	Hazard Statement Code(s)	Hazard Statement Code(s)	Supplementary Hazard Statement Code(s)	Pictograms, Signal Word Code(s)		Notes
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 2; H272: C ≥ 99 % Ox. Liq. 3; H272: 70 % ≤ C < 99 %	Note B
Skin Corr. 1A	H314	H314
Acute Tox. 1	H330	H330

Signal Words

Pictograms

Danger

Flame over circle

Corrosion

Skull and crossbones

Seveso III Data

Disclaimer: Please note that some of the substances covered by the Seveso Directive can belong to more than one Seveso categories. It will be up to the users to decide whether their substance or mixture fall in one or in more of these classification categories depending on the tonnage bands and the concentrations.
Please also note that ECHA is not an authority for the Seveso Directive and that the Seveso categorisation below is provided for information only. The Seveso III Directive (Directive 2012/18/EU repealing Directive 96/82/EC (Seveso II) from 1 June 2015) is the only authentic legal reference and that the information in this inventory does not constitute legal advice. For further information on Seveso, please ask your national authority.

Seveso Data
Seveso Substance	Seveso Categories
Sì	P8

General Information

Index Number	EC / List no.	CAS Number	International Chemical Identification
007-030-00-3	231-714-2	7697-37-2	nitric acid …% [C ≤ 70 %]

ATP Inserted / Updated: ATP15

CLP Classification (Table 3)

Classification		Labelling			Specific Concentration limits, M-Factors, Acute Toxicity Estimates (ATE)	Notes
Hazard Class and Category Code(s)	Hazard Statement Code(s)	Hazard Statement Code(s)	Supplementary Hazard Statement Code(s)	Pictograms, Signal Word Code(s)		Notes
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 3; H272: C ≥ 65 % Skin Corr. 1A; H314: C ≥ 20 % Skin Corr. 1B; H314: 5 % ≤ C < 20 % inhalation: ATE = 2.65 mg/L (Vapours)	Note B
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331

Signal Words

Pictograms

Danger

Flame over circle

Corrosion

Skull and crossbones

Seveso III Data

Seveso Data
Seveso Substance	Seveso Categories
No

Notified classification and labelling

General Information

EC / List no.	Name	CAS Number
231-714-2	Nitric acid	7697-37-2

Notified classification and labelling according to CLP criteria

Classification		Labelling			Specific Concentration limits, M-Factors	Notes	Classification affected by Impurities / Additives	Additional Notified Information	Number of Notifiers	Joint Entries
Hazard Class and Category Code(s)	Hazard Statement Code(s)	Hazard Statement Code(s)	Supplementary Hazard Statement Code(s)	Pictograms, Signal Word Code(s)	Specific Concentration limits, M-Factors	Notes	Classification affected by Impurities / Additives	Additional Notified Information	Number of Notifiers	Joint Entries
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 3; : 70 % ≤ C ≤ 99 % Ox. Liq. 2; : C ≥ 99 %	Note B		State/Form	170		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 1	H330	H330
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1A; : C ≥ 20 %	Note B		State/Form	85		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 3	H331	H331 (ATE = 2.65 mg/L...)
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr		Note B		State/Form	2022		View details
Skin Corr. 1A	H314	H314		GHS03 GHS05 Dgr		Note B		State/Form	2022		View details
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr	Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 %	Note B		State/Form	703		View details
Skin Corr. 1A	H314	H314		GHS03 GHS05 Dgr		Note B		State/Form	703		View details
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 Dgr	Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 %			State/Form	462		View details
Skin Corr. 1A	H314	H314	EUH071	GHS03 GHS05 Dgr				State/Form	462		View details
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 %			State/Form	87		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C < 99 %	Note B		State/Form	62		View details
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 1	H330	H330
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr				State/Form	60		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 1	H330	H330
Ox. Liq. 3	H272	H272		GHS03 GHS05 GHS06 Dgr				State/Form	60		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 Dgr	Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 %	Note B		State/Form	59		View details
Skin Corr. 1A	H314	H314	EUH071	GHS03 GHS05 Dgr		Note B		State/Form	59		View details
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Irrit. 2; : 1 % < C < 5 %	Note B		State/Form	55		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 3	H331	H331
		H271		Dgr	Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 %				39		View details
		H314		Dgr					39		View details
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Irrit. 2; : 1 % ≤ C < 5 % Eye Dam. 1; : C ≥ 3 % Eye Irrit. 2; : 1 % ≤ C < 3 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1A; : C ≥ 20 %				36		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 2; : C ≥ 99 % Eye Irrit. 2; : 1 % ≤ C < 3 % Eye Dam. 1; : C ≥ 3 % Ox. Liq. 3; : 70 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : C ≥ 65 % Skin Irrit. 2; : 1 % ≤ C < 5 % Skin Corr. 1A; : C ≥ 20 %				31		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 3	H331	H331
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 %			State/Form	29		View details
Skin Corr. 1A	H314	H314		GHS03 GHS05 Dgr				State/Form	29		View details
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr	Skin Corr. 1A; : C ≥ 20 % Met. Corr. 1; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 %	Note B		State/Form	26		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Ox. Liq. 3	H272	H272		GHS03 GHS05 GHS06 Dgr	Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : C ≥ 65 %			State/Form	23		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Irrit. 2; : 1 % ≤ C < 5 % Eye Dam. 1; : C ≥ 3 % Skin Corr. 1B; : 5 % ≤ C < 20 % Eye Irrit. 2; : 1 % ≤ C < 3 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 %				22		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 3	H331	H331
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr				State/Form	18		View details
Skin Corr. 1A	H314	H314		GHS03 GHS05 Dgr				State/Form	18		View details
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 %	Note B		State/Form	16		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 1	H330	H330
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 %				13		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 %	Note B			13		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 3	H331	H331
Skin Corr. 1B	H314	H314		GHS05 Dgr				State/Form	12		View details
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 %	Note B			11		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Acute Tox. 2	H330	H330
Ox. Liq. 3	H272	H272		GHS03 GHS05 GHS06 Dgr	Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 %			State/Form	7		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Acute Tox. 2	H330	H330
Ox. Liq. 3	H272	H272		GHS03 GHS08 GHS05 Dgr					6		View details
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
STOT SE 1	H370 (Respiratory tra...) (inhalation)	H370 (I)
STOT SE 1	H370 (other:Respirato...) (inhalation)	H370 (I)
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr	Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 %	Note B		State/Form	6		View details
Skin Corr. 1A	H314	H314		GHS03 GHS05 Dgr		Note B		State/Form	6		View details
Ox. Liq. 3	H272	H272 (H272)		GHS03 GHS05 Dgr		Note B			5		View details
Skin Corr. 1A	H314	H314 (H314)		GHS03 GHS05 Dgr		Note B			5		View details
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 %	Note B		State/Form	5		View details
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 Dgr	Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 % Met. Corr. 1; : C ≥ 5 % Skin Corr. 1A; : C ≥ 20 %	Note B		State/Form	4		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr	Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : C ≥ 5 %	Note B		State/Form	4		View details
Skin Corr. 1A	H314	H314		GHS03 GHS05 Dgr		Note B		State/Form	4		View details
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 Dgr				State/Form	4		View details
Skin Corr. 1A	H314	H314	EUH071	GHS03 GHS05 Dgr				State/Form	4		View details
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 Dgr	Eye Dam. 1; : C ≥ 3 % Ox. Liq. 2; : C ≥ 99 % Eye Irrit. 2; : C < 3 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Irrit. 2; : C < 3 %	Note B		State/Form	3		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Skin Corr. 1A	H314	H314		GHS05 Dgr	Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : C ≥ 5 %	Note B		State/Form	2		View details
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 %	Note B		State/Form	2		View details
		H290
Skin Corr. 1A	H314	H314
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Met. Corr. 1; : C ≥ .2 % Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 %	Note B		State/Form	2		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Eye Dam. 1; : C ≥ 3 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Irrit. 2; : 1 % < C < 5 % Eye Irrit. 2; : 1 % < C < 3 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 2; : C ≥ 99 %	Note B			2		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Met. Corr. 1	H290	H290	EUH071	GHS05 GHS06 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 %	Note B		State/Form	2		View details
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr	Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 % Skin Corr. 1B; : 5 % ≤ C < 20 %	Note B		State/Form	1		View details
Met. Corr. 1	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Not Classified									1
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 %	Note B Note 2 Note 1		State/Form	1		View details
Met. Corr. 1	H290	H290
Acute Tox. 4	H302
Skin Corr. 1A	H314	H314
Ox. Sol. 2	H272	H272		GHS03 GHS07 GHS05 GHS09 GHS06 Dgr					1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 1	H330	H330
		H335
Acute Tox. 1	H330	H330		GHS06 Dgr				State/Form	1		View details
Ox. Liq. 1	H271	H271		GHS03 Dgr				State/Form	1		View details
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C < 100 % Skin Corr. 1A; : 20 % ≤ C < 100 %	Note B			1		View details
Skin Corr. 1A	H314	H314		GHS03 GHS05 Dgr		Note B			1		View details
Met. Corr. 1	H290	H290		GHS08 GHS05 GHS06 Dgr				State/Form	1		View details
Asp. Tox. 1	H304	H304
Skin Corr. 1B	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 2	H330	H330
STOT SE 1	H370 (Respiratory Sys...)	H370
STOT SE 1	H370 (other:Respirato...)	H370
STOT RE 1	H372 (Respiratory Sys...)	H372
STOT RE 1	H372 (other:Respirato...)	H372
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 Dgr	Skin Corr. 1B; : 5 % ≤ C ≤ 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 %			State/Form	1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Ox. Liq. 3	H272	H272		GHS03 GHS05 Dgr	Skin Corr. 1A; : C > 20 %	Note B		State/Form	1		View details
Skin Corr. 1A	H314	H314		GHS03 GHS05 Dgr	Skin Corr. 1A; : C > 20 %	Note B		State/Form	1		View details
Ox. Liq. 3	H272	H272		GHS07 GHS05 Dgr				State/Form	1		View details
Skin Corr. 1A	H314	H314		GHS07 GHS05 Dgr				State/Form	1		View details
		H272 (H314)		GHS03 GHS05 Dgr				State/Form	1		View details
Ox. Liq. 2	H272	H272		GHS03 GHS05 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 %			State/Form	1		View details
Skin Corr. 1A	H314	H314		GHS03 GHS05 Dgr				State/Form	1		View details
Skin Corr. 1A	H314	H314		GHS05 Dgr				State/Form	1		View details
Ox. Liq. 2	H272	H272		GHS03 GHS05 Dgr				State/Form	1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 %				1		View details
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS07 GHS05 Dgr	Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 %			State/Form	1		View details
Skin Corr. 1A	H314	H314
		H315
		H319
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 %				1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 Dgr	Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 %	Note B			1		View details
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 Dgr	Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 %	Note B		State/Form	1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 3; : 65 % ≤ C < 70 % Ox. Liq. 2; : C ≥ 70 % Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 %	Note B			1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 3	H331	H331
Aquatic Chronic 3	H412	H412
Met. Corr. 1	H290	H290	EUH071	GHS05 GHS06 Dgr	Ox. Liq. 2; : C ≥ 99 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 %	Note B			1		View details
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 2; : C ≥ 99 %	Note B		State/Form	1		View details
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 %	Note B			1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Acute Tox. 1	H330	H330
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Corr. 1A; : 20 % ≤ C ≤ 100 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C ≤ 100 %				1		View details
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Ox. Liq. 2; : C ≥ 99 %	Note B		State/Form	1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Corr. 1A; : C ≥ 20 % Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C < 100 %	Note B			1		View details
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Ox. Liq. 2; : C ≥ 99 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : 65 % ≤ C < 99 % Skin Corr. 1B; : 5 % ≤ C < 20 %	Note B			1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Ox. Liq. 3; : 65 % ≤ C < 100 % Skin Corr. 1A; : C ≥ 20 %	Note B			1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1B	H314	H314
Eye Dam. 1	H318	H318
Acute Tox. 3	H331	H331
Ox. Liq. 2	H272	H272		GHS03 GHS05 GHS06 Dgr		Note B			1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Acute Tox. 3	H331	H331
Ox. Liq. 3	H272	H272	EUH071	GHS03 GHS05 GHS06 Dgr	Skin Corr. 1B; : 5 % ≤ C < 20 % Skin Corr. 1A; : C ≥ 20 % Ox. Liq. 3; : C ≥ 65 %			State/Form	1		View details
Met. Corr. 1	H290	H290
Skin Corr. 1A	H314	H314
Eye Dam. 1	H318
Acute Tox. 3	H331	H331

Number of Aggregated Notifications: 69